Pharmaceuticals Global On demand · 24-48h

Global Astragalus Extract Market Strategic Research Report

Global Astragalus Extract Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Astragalus Extract Market
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Astragalus Polysaccharide, Astragaloside IV

By Application: Healthy Food, Pharmaceutical Industry, Feed Additives, Other

Key Players: Euromed SA, XI`AN GAOYUAN BIO-CHEM, World-way Biotech, Zhe Jiang Skyherb Biotechnology, Xinxiang Bokai Biological, Acetar Bio-Tech, Ningxian hengrui kang biological, Shaanxi Jiahe Phytochem, Xi'an Rainbow Biotech, CHANGSHA ORGANIC HERB, Xi`an Green Spring Technology, Inner Mongolia Ever Brilliance Biotechnology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2024 · forecast to 2032
Length: 131 pages

Visão geral

Scope of the Report

Astragalus, a traditional Chinese medicinal herb, is derived from the dried roots of Astragalus membranaceus and Astragalus mongholicus, both belonging to the legume family. This herb is primarily cultivated in the Loess Plateau regions of Shanxi, Shaanxi, and Henan in China. According to the pharmacopoeia, the roots of Astragalus contain various active compounds, including polysaccharides, flavonoids, saponins, amino acids, and trace elements. It is traditionally used to treat symptoms related to Qi deficiency, such as fatigue, spontaneous sweating, hypertension, diabetes, edema, and chronic wounds. Modern medical research shows that Astragalus can help prevent colds and enhance immune function. Its extract is known for its anti-inflammatory, analgesic, hypoxia-resistant, and anti-fatigue properties.

Astragalus Extract has gained significant attention in recent years, driven by the rapid growth of the health and nutrition industry. As a traditional herbal medicine, Astragalus is widely used for immune enhancement, anti-fatigue, and anti-aging purposes. The market demand has steadily increased, especially in the fields of health supplements, functional foods, and herbal medicines. The growing preference for natural ingredients and plant extracts among consumers gives the Astragalus Extract market strong growth potential. Additionally, advancements in biotechnology and scientific research have expanded the range of applications for Astragalus, particularly in pharmaceuticals, such as cancer treatment and antiviral research.

Looking ahead, the market for Astragalus Extract shows a positive development trend. Firstly, the growing demand for health products, particularly in immune boosting and anti-aging areas, continues to fuel market growth. Secondly, with the internationalization of traditional Chinese medicine, the recognition of Astragalus Extract in global markets, especially in developed countries such as Europe and the United States, is increasing. Furthermore, advancements in bio-extraction technology may lower the production costs of Astragalus Extract, thereby expanding its reach and market share.

However, the Astragalus Extract market also faces certain drivers and obstacles. On the one hand, the supply of raw materials may be affected by climate change and agricultural conditions, impacting the stable availability of products. On the other hand, despite the widespread recognition of Astragalus' benefits, there are still challenges in scientific validation, and consumer skepticism about the effectiveness of the product may hinder further market expansion. Additionally, with fierce market competition, smaller companies may struggle to compete with larger firms in terms of technological innovation and brand development, limiting their market share growth.

This report presents a comprehensive overview of the global Astragalus Extract market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Astragalus Polysaccharide
  • Astragaloside IV

Segment by Application

  • Healthy Food
  • Pharmaceutical Industry
  • Feed Additives
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Astragalus Extract market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Healthy Food, Pharmaceutical Industry, Feed Additives evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Segments covered in this report

By Type
Astragalus PolysaccharideAstragaloside IV
By Application
Healthy FoodPharmaceutical IndustryFeed AdditivesOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Astragalus Polysaccharide
  • 3.1.3 Astragaloside IV
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Healthy Food
  • 4.1.3 Pharmaceutical Industry
  • 4.1.4 Feed Additives
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Euromed SA
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 XI`AN GAOYUAN BIO-CHEM
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 World-way Biotech
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Zhe Jiang Skyherb Biotechnology
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Xinxiang Bokai Biological
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Acetar Bio-Tech
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Ningxian hengrui kang biological
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Shaanxi Jiahe Phytochem
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Xi'an Rainbow Biotech
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 CHANGSHA ORGANIC HERB
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Xi`an Green Spring Technology
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Inner Mongolia Ever Brilliance Biotechnology
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What does the Astragalus Extract market cover?
Astragalus Extract has gained significant attention in recent years, driven by the rapid growth of the health and nutrition industry. As a traditional herbal medicine, Astragalus is widely used for immune enhancement, anti-fatigue, and anti-aging purposes. The market demand has steadily increased, especially in the fields of health supplements, functional foods, and herbal medicines.
What are the main segments of the Astragalus Extract market by type?
By type, the market is segmented into Astragalus Polysaccharide and Astragaloside IV.
Which applications drive demand in the Astragalus Extract market?
Key applications covered include Healthy Food, Pharmaceutical Industry, Feed Additives and Other.
Who are the key players in the Astragalus Extract market?
Key players profiled include Euromed SA, XI`AN GAOYUAN BIO-CHEM, World-way Biotech, Zhe Jiang Skyherb Biotechnology, Xinxiang Bokai Biological, Acetar Bio-Tech, Ningxian hengrui kang biological and Shaanxi Jiahe Phytochem, among 12 companies covered in total.
Which regions and countries are covered for Astragalus Extract?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Astragalus Extract market?
Astragalus Extract has gained significant attention in recent years, driven by the rapid growth of the health and nutrition industry.
What challenges does the Astragalus Extract market face?
On the other hand, despite the widespread recognition of Astragalus' benefits, there are still challenges in scientific validation, and consumer skepticism about the effectiveness of the product may hinder further market expansion.
Who should buy the Astragalus Extract market report?
The report is intended for manufacturers and solution providers, distributors and end users in Healthy Food, Pharmaceutical Industry and Feed Additives, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Astragalus Extract market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.